X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (534) 534
humans (513) 513
index medicus (392) 392
5 alpha-reductase (290) 290
animals (285) 285
endocrinology & metabolism (248) 248
5α-reductase (246) 246
testosterone (225) 225
finasteride (222) 222
benign prostatic hyperplasia (202) 202
female (199) 199
urology & nephrology (178) 178
biochemistry & molecular biology (163) 163
dihydrotestosterone (156) 156
prostate (148) 148
rats (147) 147
middle aged (146) 146
expression (137) 137
men (137) 137
steroid 5-alpha-reductase (131) 131
prostate cancer (119) 119
aged (114) 114
cholestenone 5 alpha-reductase (114) 114
androgens (113) 113
pharmacology & pharmacy (113) 113
androgen receptor (108) 108
dutasteride (107) 107
adult (106) 106
3-oxo-5-alpha-steroid 4-dehydrogenase - metabolism (101) 101
neurosciences (101) 101
prostatic hyperplasia - drug therapy (89) 89
cholestenone 5 alpha-reductase - metabolism (88) 88
3-oxo-5-alpha-steroid 4-dehydrogenase - genetics (87) 87
hyperplasia (82) 82
5 alpha-reductase inhibitors (78) 78
enzymes (77) 77
mice (76) 76
cancer (75) 75
testosterone - metabolism (75) 75
5α-reductase inhibitors (71) 71
rat (71) 71
finasteride - pharmacology (70) 70
male pseudohermaphroditism (69) 69
chemistry, medicinal (67) 67
enzyme inhibitors - pharmacology (65) 65
dihydrotestosterone - metabolism (64) 64
oxidoreductases - metabolism (64) 64
cholestenone 5 alpha-reductase - antagonists & inhibitors (63) 63
5-alpha reductase inhibitors - pharmacology (59) 59
5 alpha-reductase inhibitor (58) 58
progesterone (58) 58
metabolism (57) 57
aromatase (56) 56
aged, 80 and over (55) 55
gene expression (55) 55
analysis (54) 54
5-alpha reductase inhibitors (53) 53
5α-reductase inhibitor (53) 53
physiological aspects (53) 53
receptor (53) 53
treatment outcome (53) 53
androgens - metabolism (52) 52
urinary-tract symptoms (52) 52
5-alpha reductase inhibitors - therapeutic use (51) 51
5-alpha-reductase (51) 51
growth (51) 51
gene-expression (50) 50
risk (50) 50
bph (49) 49
cell biology (49) 49
brain (48) 48
rats, sprague-dawley (48) 48
article (47) 47
dose-response relationship, drug (47) 47
prostate - drug effects (46) 46
dermatology (45) 45
oxidoreductases - antagonists & inhibitors (45) 45
tissue distribution (45) 45
androgen (44) 44
enzyme inhibitors - therapeutic use (44) 44
erectile dysfunction (44) 44
finasteride - therapeutic use (44) 44
oncology (44) 44
reductase (44) 44
risk factors (44) 44
rna, messenger - metabolism (44) 44
testosterone - blood (44) 44
estrogen (43) 43
hypertrophy (43) 43
lower urinary tract symptoms (43) 43
urology (43) 43
cells (42) 42
neuroactive steroids (42) 42
mutation (41) 41
5α‐reductase (40) 40
adolescent (40) 40
neurosteroids (40) 40
receptors, androgen - metabolism (40) 40
steroids (40) 40
care and treatment (39) 39
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
UofT at Scarborough - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


INTERNATIONAL JOURNAL OF CANCER, ISSN 0020-7136, 01/2007, Volume 120, Issue 2, pp. 285 - 291
Previous in vitro studies demonstrated that bioactive androgen 5 alpha-dihydrotestosterone (DHT) exerted antiproliferative effects through an interaction with... 
PROGNOSTIC FACTORS | androgen | aromatase | breast cancer | RANDOMIZED-TRIAL | RECEPTOR | CELL-PROLIFERATION | CANCER | TAMOXIFEN THERAPY | androgen receptor | ONCOLOGY | GROWTH | ESTROGEN | ESTRADIOL LEVELS | POSTMENOPAUSAL WOMEN | 5 alpha-reductase
Journal Article
JOURNAL OF SUPERCRITICAL FLUIDS, ISSN 0896-8446, 11/2011, Volume 59, pp. 61 - 71
The three crude extracts including Oryza sativa (bran) from supercritical carbon dioxide fluid (scCO(2)) process which gave the highest unsaturated fatty acid... 
CELLS | UNSATURATED FATTY-ACIDS | LINOLEIC-ACID | RICE BRAN | CHEMISTRY, PHYSICAL | STEROID 5-ALPHA-REDUCTASE | ENGINEERING, CHEMICAL | Unsaturated fatty acids | IN-VITRO | ANDROGENETIC ALOPECIA | OIL | PROSTATE-CANCER | GROWTH | Antioxidation | O. sativa crude extract | Supercritical carbon dioxide (scCO) | 5 alpha-Reductase inhibition
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Steroids, ISSN 0039-128X, 2002, Volume 67, Issue 10, pp. 859 - 867
Journal Article
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 2007, Volume 264, Issue 1, pp. 171 - 183
Journal Article
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2007, Volume 53, Issue 2, pp. 244 - 252
Journal Article
Acta Biologica Hungarica, ISSN 0236-5383, 09/2010, Volume 61, Issue 3, pp. 274 - 281
The 5 alpha-reductase type 1 isozyme is a key enzyme in the metabolism of the androgen steroid hormones and inhibitors of this enzyme represent a new... 
exo -heterocyclic steroids | 5α-reductase inhibitors | finasteride | rat liver | PROSTATE | TESTOSTERONE | exo-heterocyclic steroids | IN-VITRO | MESSENGER-RNA | METABOLISM | TISSUE DISTRIBUTION | RT-PCR | BIOSYNTHESIS | BIOLOGY | 5 alpha-reductase inhibitors | PRECISE QUANTITATION | EXPRESSION
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 11/2014, Volume 22, Issue 21, pp. 6233 - 6241
It is well known that testosterone (T) under the influence of 5α-reductase enzyme is converted to dihydrotestosterone (DHT), which causes androgen-dependent... 
Benign prostatic hyperplasia | Dehydroepiandrosterone derivatives | 5α-Reductase type 1 inhibitors | Prostate cancer | IN-VITRO | CHEMISTRY, MEDICINAL | RAT | BIOCHEMISTRY & MOLECULAR BIOLOGY | 5 alpha-Reductase type 1 inhibitors | CHEMISTRY, ORGANIC | INHIBITORS | Prostatic Neoplasms - metabolism |